![Hyo Min Park](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Hyo Min Park is associated with the firm GenEdit, Inc. as the Chief Technology Officer since 2016.
Dr. Park is the founder of GenEdit, Inc. which was founded in 2016.
Postes actifs de Hyo Min Park
Sociétés | Poste | Début |
---|---|---|
GenEdit, Inc.
![]() GenEdit, Inc. Pharmaceuticals: MajorHealth Technology GenEdit, Inc. develops gene therapies and gene editing-based therapeutics. Its proprietary nanoparticles applies for the development of CRISPR-based therapeutics and gene therapy products for a range of genetic diseases. The company was founded by Kunwoo Lee, Niren Murthy, and Hyo Min Park in 2016 and is headquartered in Berkeley, CA. | Fondateur | 01/01/2016 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
GenEdit, Inc.
![]() GenEdit, Inc. Pharmaceuticals: MajorHealth Technology GenEdit, Inc. develops gene therapies and gene editing-based therapeutics. Its proprietary nanoparticles applies for the development of CRISPR-based therapeutics and gene therapy products for a range of genetic diseases. The company was founded by Kunwoo Lee, Niren Murthy, and Hyo Min Park in 2016 and is headquartered in Berkeley, CA. | Health Technology |